Skip to main content

ORIGINAL RESEARCH article

Front. Nutr.
Sec. Nutritional Epidemiology
Volume 12 - 2025 | doi: 10.3389/fnut.2025.1473487
This article is part of the Research Topic Eating Behavior and Chronic Diseases: Research Evidence from Population Studies, Volume II View all 5 articles

Association between the Composite Dietary Antioxidant Index and Nonalcoholic Fatty Liver Disease: Evidence from National Health and Nutrition Examination Survey 2005-2016

Provisionally accepted
Yidian Fu Yidian Fu 1Chao Jiang Chao Jiang 2Zonglin Li Zonglin Li 3Xiangyun Shi Xiangyun Shi 4Jingbo Zhang Jingbo Zhang 5,6*Peiyuan Lv Peiyuan Lv 1,7*
  • 1 Graduate School of Hebei Medical University, Shijiazhuang, Hebei Province, China
  • 2 Graduate School, Hebei North University, Zhangjiakou, Hebei Province, China
  • 3 Liaocheng Traditional Chinese Medicine Hospital, Liaocheng, Shandong Province, China
  • 4 Sichuan Normal University, Chengdu, Sichuan Province, China
  • 5 First Affiliated Hospital of Chongqing Medical University, Chongqing, China
  • 6 Graduate School of Medicine, Osaka University, Suita, Ōsaka, Japan
  • 7 Department of Neurology, Hebei General Hospital, Shijiazhuang, Hebei Province, China

The final, formatted version of the article will be published soon.

    Importance: Oxidative stress contributes to the progression of nonalcoholic fatty liver disease (NAFLD). Antioxidants from food can reduce NAFLD incidence, and the Composite Dietary Antioxidant Index (CDAI) measures total antioxidant capacity (TAC). However, the relationship between CDAI and NAFLD in the US adult population remains unclear. Objective: To assess whether CDAI is associated with NAFLD in US adults. Design, setting, and participants: This population-based cross-sectional study used data on US adults from the National Health and Nutrition Examination Survey (NHANES) 2005-2016 cycles. Data were analyzed from January to February 2024. Exposures: CDAI obtained from the dietary intake questionnaire. Main outcomes and measures: The main outcome was NAFLD which defined by the US fatty liver score (USFLI) ≥ 30. Sampling weights were calculated according to NHANES guidelines. Results: Among 9746 adults included in this study (mean age, 48.3 years; 4662 [47.6%] males), 3324 (33.0%) were classified as having NAFLD using USFLI. In the fully adjusted of multivariable logistic regression, CDAI was negatively associated with NAFLD (odds ratio [OR], 0.95; 95% CI, 0.93-0.98). Furthermore, individuals in the highest quartile of CDAI were 34% less likely to have NAFLD compared to those in the lowest quartile. (OR, 0.66; 95% CI, 0.52-0.85). In subgroup analyses, CDAI was inversely associated with NAFLD among participants with a BMI < 25 (OR, 0.89; 95% CI, 0.83–0.95) and without metabolic syndrome (OR, 0.93; 95% CI, 0.91–0.96). The interaction tests revealed significant differences in these subgroups (P for interaction = 0.04 for BMI and 0.003 for metabolic syndrome). Sensitivity analyses confirmed this association using the hepatic steatosis index (HSI) to define NAFLD, applying unweighted logistic regression, adjusting for physical activity or after excluding non-Hispanic Black participants, and after excluding medications known for their potential hepatotoxic effects. Conclusions and relevance: In this cross-sectional study based on six cycles (2005-2016) of the NHANES, CDAI was negatively associated with NAFLD in US adult population. This association highlights the potential for dietary interventions to reduce NAFLD incidence and underscores the need for future research, including clinical trials and mechanistic studies, to further explore the role of dietary antioxidants in NAFLD prevention and management.

    Keywords: This population-based cross-sectional study used Composite dietary antioxidant index, Non-alcoholic fatty liver disease, NHANES, US fatty liver index, Hepatic Steatosis Index

    Received: 31 Jul 2024; Accepted: 06 Jan 2025.

    Copyright: © 2025 Fu, Jiang, Li, Shi, Zhang and Lv. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Jingbo Zhang, First Affiliated Hospital of Chongqing Medical University, Chongqing, China
    Peiyuan Lv, Graduate School of Hebei Medical University, Shijiazhuang, Hebei Province, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.